Birdwatch Archive

Birdwatch Note Rating

2023-04-21 22:14:54 UTC - NOT_HELPFUL

Rated by Participant: FFAAEA6CD4AB58911686667415D39B5F02FF3484BF4060EE0CA7F95F50A1C7FC
Participant Details

Original Note:

Ivermectin tablets are approved by the FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms. Randomized controlled trials show Ivermectin does not have efficacy in COVID-19, cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://www.reuters.com/article/factcheck-nobel-ivermectin/fact-check-2015-nobel-prize-for-ivermectin-intended-for-treatment-of-parasitic-infections-doesnt-prove-its-efficacy-on-covid-19-idUSL1N2QB2XA https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662

All Note Details

Original Tweet

All Information

  • noteId - 1649444853502164997
  • participantId -
  • raterParticipantId - FFAAEA6CD4AB58911686667415D39B5F02FF3484BF4060EE0CA7F95F50A1C7FC
  • createdAtMillis - 1682115294901
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1649444853502164997FFAAEA6CD4AB58911686667415D39B5F02FF3484BF4060EE0CA7F95F50A1C7FC